- Novo Nordisk's Victoza helps patients achieve blood-sugar control when switching from exenatide or sitagliptin
- Adherence among chronic disease patients can lead to big savings
- IAF: 10 U.S. states will see highest diabetes prevalence, cost
- Giant Eagle announces free in-store diabetes screenings
- Novo Nordisk develops Cornerstones4Care as diabetes resource
ORLANDO, Fla. — Danish drug maker Novo Nordisk will work with advocacy group Children with Diabetes to distribute materials to children newly diagnosed with Type 1 diabetes, the two said Thursday.
The approximately 7,000 kits, designed to help them learn to live with the condition, include a booklet, savings offers and patient-support videos, and were created based on feedback from CWD members with Type 1 diabetes. Patients can order the kits through their doctors.
Approximately 15,600 children and adolescents in the United States are diagnosed with Type 1 diabetes every year, according to Novo Nordisk and CWD.